{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,15]],"date-time":"2026-09-15T23:49:55Z","timestamp":1789516195685,"version":"build-2803163510"},"reference-count":65,"publisher":"MDPI AG","issue":"3","license":[{"start":{"date-parts":[[2019,3,15]],"date-time":"2019-03-15T00:00:00Z","timestamp":1552608000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Sports"],"abstract":"<jats:p>Precision medicine is being discussed and incorporated at all levels of health care and disease prevention, management, and treatment. Key components include new taxonomies of disease classification, the measurement and incorporation of genetics and \u201comics\u201d data, biomarkers, and health care professionals who can optimize this information for a precision approach to treatment. The study and treatment of Duchenne Muscular Dystrophy is making rapid advances in these areas in addition to rapid advances in new gene and cell-based therapies. New therapies will increase the variability in disease severity, furthering a need for a precision-based approach. An area of therapy that is rarely considered in this approach is how the physiology of muscle contractions will interact with these therapies and a precision approach. As muscle pathology improves, physical activity levels will increase, which will likely be very beneficial to some patients but likely not to all. Physical activity is likely to synergistically improve these therapies and can be used to enhance muscle health and quality of life after these therapies are delivered using the tools of precision medicine.<\/jats:p>","DOI":"10.3390\/sports7030064","type":"journal-article","created":{"date-parts":[[2019,3,18]],"date-time":"2019-03-18T04:06:55Z","timestamp":1552882015000},"page":"64","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":18,"title":["Precision Medicine and Exercise Therapy in Duchenne Muscular Dystrophy"],"prefix":"10.3390","volume":"7","author":[{"given":"Matthew","family":"Kostek","sequence":"first","affiliation":[{"name":"Laboratory of Muscle and Translational Therapeutics, Department of Physical Therapy, Duquesne University, Pittsburgh, PA 15228, USA"},{"name":"McGowan Institute of Regenerative Medicine, University of Pittsburgh School of Medicine, Pittsburgh, PA 15228, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2019,3,15]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1161\/CIRCULATIONAHA.115.019475","article-title":"Opportunities for the Cardiovascular Community in the Precision Medicine Initiative","volume":"133","author":"Shah","year":"2016","journal-title":"Circulation"},{"key":"ref_2","first-page":"30","article-title":"Fundamentals of Precision Medicine","volume":"38","author":"Divaris","year":"2017","journal-title":"Compend. Contin. Educ. Dent."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"784","DOI":"10.1007\/s00125-017-4207-5","article-title":"Lifestyle and precision diabetes medicine: Will genomics help optimise the prediction, prevention and treatment of type 2 diabetes through lifestyle therapy?","volume":"60","author":"Franks","year":"2017","journal-title":"Diabetologia"},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1007\/s40279-013-0018-0","article-title":"Toward exercise as personalized medicine","volume":"43","author":"Buford","year":"2013","journal-title":"Sports Med."},{"key":"ref_5","unstructured":"National Research Council (2011). Toward Precision Medicine: Building a Knowledge Network for Biomedical Research and a New Taxonomy of Disease, National Academies Press."},{"key":"ref_6","doi-asserted-by":"crossref","unstructured":"Joyner, M.J., and Paneth, N. (2019). Promises, promises, and precision medicine. J. Clin. Investig., 129.","DOI":"10.1172\/JCI126119"},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1001\/jama.2015.17142","article-title":"Value of Personalized Medicine\u2014Reply","volume":"315","author":"Joyner","year":"2016","journal-title":"JAMA"},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1001\/jama.2015.17136","article-title":"Value of Personalized Medicine","volume":"315","author":"Snyderman","year":"2016","journal-title":"JAMA"},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"694","DOI":"10.1377\/hlthaff.2017.1624","article-title":"Precision Medicine: From Science To Value","volume":"37","author":"Ginsburg","year":"2018","journal-title":"Health Aff. (Millwood)"},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"803","DOI":"10.1016\/j.nmd.2018.06.009","article-title":"Personalized gene and cell therapy for Duchenne Muscular Dystrophy","volume":"28","author":"Barthelemy","year":"2018","journal-title":"Neuromuscul. Disord."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"926","DOI":"10.1016\/S0960-8966(02)00140-2","article-title":"Survival in Duchenne muscular dystrophy: Improvements in life expectancy since 1967 and the impact of home nocturnal ventilation","volume":"12","author":"Eagle","year":"2002","journal-title":"Neuromuscul. Disord."},{"key":"ref_12","first-page":"121","article-title":"Improvement of survival in Duchenne Muscular Dystrophy: Retrospective analysis of 835 patients","volume":"31","author":"Passamano","year":"2012","journal-title":"Acta Myol."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"293","DOI":"10.5692\/clinicalneurol.53.293","article-title":"Two cases of Duchenne muscular dystrophy over 40 years after onset","volume":"53","author":"Ishizaki","year":"2013","journal-title":"Rinsho Shinkeigaku"},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"1110","DOI":"10.1177\/0883073810371003","article-title":"Cardiac and pulmonary function variability in Duchenne\/Becker muscular dystrophy: An initial report","volume":"25","author":"Birnkrant","year":"2010","journal-title":"J. Child Neurol."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1016\/j.ejpn.2011.07.001","article-title":"Motor and respiratory heterogeneity in Duchenne patients: Implication for clinical trials","volume":"16","author":"Humbertclaude","year":"2012","journal-title":"Eur. J. Paediatr. Neurol."},{"key":"ref_16","first-page":"111","article-title":"Studies in disorders of muscle. V. The inheritance of childhood progressive muscular dystrophy in 33 kindreds","volume":"3","author":"Stephens","year":"1951","journal-title":"Am. J. Hum. Genet."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1007\/BF02825937","article-title":"Duchenne\u2019s muscular dystrophy in monozygotic twins","volume":"51","author":"Radhakrishnan","year":"1984","journal-title":"Indian J. Pediatr."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1002\/ajmg.1320330116","article-title":"Duchenne muscular dystrophy in monozygotic twins: Deletion of 5\u2019 fragments of the gene","volume":"33","author":"Ionasescu","year":"1989","journal-title":"Am. J. Med. Genet."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1249\/JES.0000000000000131","article-title":"Exercise Is an Adjuvant to Contemporary Dystrophy Treatments","volume":"46","author":"Kostek","year":"2018","journal-title":"Exerc. Sport Sci. Rev."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1152\/physiolgenomics.00138.2004","article-title":"Polymorphisms in the osteopontin promoter affect its transcriptional activity","volume":"20","author":"Giacopelli","year":"2004","journal-title":"Physiol. Genom."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1111\/j.1744-313X.2009.00855.x","article-title":"A genetic polymorphism in transforming growth factor beta receptor-2 is associated with serum osteopontin","volume":"36","author":"Biros","year":"2009","journal-title":"Int. J. Immunogenet."},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"1583","DOI":"10.1172\/JCI37662","article-title":"Osteopontin promotes fibrosis in dystrophic mouse muscle by modulating immune cell subsets and intramuscular TGF-beta","volume":"119","author":"Vetrone","year":"2009","journal-title":"J. Clin. Investig."},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"1858","DOI":"10.1212\/WNL.0b013e318239b9ae","article-title":"SPP1 genotype is a determinant of disease severity in Duchenne muscular dystrophy: Predicting the severity of Duchenne muscular dystrophy: Implications for treatment","volume":"77","author":"Kyriakides","year":"2011","journal-title":"Neurology"},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"684","DOI":"10.1002\/ana.24370","article-title":"Genetic modifiers of ambulation in the Cooperative International Neuromuscular Research Group Duchenne Natural History Study","volume":"77","author":"Bello","year":"2015","journal-title":"Ann. Neurol."},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1002\/path.4026","article-title":"TGFBR2 but not SPP1 genotype modulates osteopontin expression in Duchenne muscular dystrophy muscle","volume":"228","author":"Piva","year":"2012","journal-title":"J. Pathol."},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"1060","DOI":"10.1136\/jnnp-2014-308409","article-title":"Validation of genetic modifiers for Duchenne muscular dystrophy: A multicentre study assessing SPP1 and LTBP4 variants","volume":"86","author":"Hiller","year":"2015","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"1163","DOI":"10.1016\/j.ajhg.2016.08.023","article-title":"Association Study of Exon Variants in the NF-kappaB and TGFbeta Pathways Identifies CD40 as a Modifier of Duchenne Muscular Dystrophy","volume":"99","author":"Bello","year":"2016","journal-title":"Am. J. Hum. Genet."},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"14143","DOI":"10.1038\/ncomms14143","article-title":"Evidence for ACTN3 as a genetic modifier of Duchenne muscular dystrophy","volume":"8","author":"Hogarth","year":"2017","journal-title":"Nat. Commun."},{"key":"ref_29","doi-asserted-by":"crossref","unstructured":"Del Coso, J., Hiam, D., Houweling, P., Perez, L.M., Eynon, N., and Lucia, A. (2018). More than a \u2018speed gene\u2019: ACTN3 R577X genotype, trainability, muscle damage, and the risk for injuries. Eur. J. Appl. Physiol.","DOI":"10.1007\/s00421-018-4010-0"},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"949","DOI":"10.1126\/science.175.4025.949","article-title":"Gene therapy for human genetic disease?","volume":"175","author":"Friedmann","year":"1972","journal-title":"Science"},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1093\/jnci\/92.2.98","article-title":"Gene therapy death\u2014\u201ceveryone has to share in the guilt\u201d","volume":"92","author":"Jenks","year":"2000","journal-title":"J. Natl. Cancer Inst."},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"1031","DOI":"10.1016\/j.ymthe.2006.03.001","article-title":"Genotoxicity of retroviral integration in hematopoietic cells","volume":"13","author":"Nienhuis","year":"2006","journal-title":"Mol. Ther."},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"1648","DOI":"10.1038\/mt.2008.171","article-title":"Self-complementary AAV vectors; advances and applications","volume":"16","author":"McCarty","year":"2008","journal-title":"Mol. Ther."},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1002\/mus.20586","article-title":"Entries in the Leiden Duchenne muscular dystrophy mutation database: An overview of mutation types and paradoxical cases that confirm the reading-frame rule","volume":"34","author":"Fokkema","year":"2006","journal-title":"Muscle Nerve"},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"915","DOI":"10.1002\/mus.24151","article-title":"Exercise increases utrophin protein expression in the mdx mouse model of Duchenne muscular dystrophy","volume":"49","author":"Gordon","year":"2014","journal-title":"Muscle Nerve"},{"key":"ref_36","first-page":"232","article-title":"Mechanical signals, IGF-I gene splicing, and muscle adaptation","volume":"20","author":"Goldspink","year":"2005","journal-title":"Physiology (Bethesda)"},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"1718","DOI":"10.1038\/mt.2013.111","article-title":"Reading frame correction by targeted genome editing restores dystrophin expression in cells from Duchenne muscular dystrophy patients","volume":"21","author":"Ousterout","year":"2013","journal-title":"Mol. Ther."},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"868","DOI":"10.1038\/nmeth.3993","article-title":"A multifunctional AAV-CRISPR-Cas9 and its host response","volume":"13","author":"Chew","year":"2016","journal-title":"Nat. Methods"},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1038\/nature14299","article-title":"In vivo genome editing using Staphylococcus aureus Cas9","volume":"520","author":"Ran","year":"2015","journal-title":"Nature"},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1016\/j.stem.2016.01.021","article-title":"A Single CRISPR-Cas9 Deletion Strategy that Targets the Majority of DMD Patients Restores Dystrophin Function in hiPSC-Derived Muscle Cells","volume":"18","author":"Young","year":"2016","journal-title":"Cell Stem Cell"},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1038\/337176a0","article-title":"Conversion of mdx myofibres from dystrophin-negative to-positive by injection of normal myoblasts","volume":"337","author":"Partridge","year":"1989","journal-title":"Nature"},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"1113","DOI":"10.1083\/jcb.144.6.1113","article-title":"Dynamics of myoblast transplantation reveal a discrete minority of precursors with stem cell-like properties as the myogenic source","volume":"144","author":"Beauchamp","year":"1999","journal-title":"J. Cell Biol."},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"975","DOI":"10.1002\/mus.880170903","article-title":"Utilization of myoblasts from transgenic mice to evaluate the efficacy of myoblast transplantation","volume":"17","author":"Kinoshita","year":"1994","journal-title":"Muscle Nerve"},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1172\/JCI20325","article-title":"Human circulating AC133(+) stem cells restore dystrophin expression and ameliorate function in dystrophic skeletal muscle","volume":"114","author":"Torrente","year":"2004","journal-title":"J. Clin. Investig."},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1186\/s12014-016-9109-x","article-title":"Clinical utility of serum biomarkers in Duchenne muscular dystrophy","volume":"13","author":"Hathout","year":"2016","journal-title":"Clin. Proteom."},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1002\/emmm.201100133","article-title":"miRNAs as serum biomarkers for Duchenne muscular dystrophy","volume":"3","author":"Cacchiarelli","year":"2011","journal-title":"EMBO Mol. Med."},{"key":"ref_47","doi-asserted-by":"crossref","first-page":"2885","DOI":"10.1016\/j.ajpath.2014.07.021","article-title":"Serum profiling identifies novel muscle miRNA and cardiomyopathy-related miRNA biomarkers in Golden Retriever muscular dystrophy dogs and Duchenne muscular dystrophy patients","volume":"184","author":"Lameth","year":"2014","journal-title":"Am. J. Pathol."},{"key":"ref_48","doi-asserted-by":"crossref","first-page":"3960","DOI":"10.1093\/hmg\/ddw237","article-title":"Selective release of muscle-specific, extracellular microRNAs during myogenic differentiation","volume":"25","author":"Betts","year":"2016","journal-title":"Hum. Mol. Genet."},{"key":"ref_49","doi-asserted-by":"crossref","first-page":"585","DOI":"10.3109\/1354750X.2014.952663","article-title":"Circulating miR-1, miR-133a, and miR-206 levels are increased after a half-marathon run","volume":"19","author":"Gomes","year":"2014","journal-title":"Biomarkers"},{"key":"ref_50","doi-asserted-by":"crossref","unstructured":"Mizuno, H., Nakamura, A., Aoki, Y., Ito, N., Kishi, S., Yamamoto, K., Sekiguchi, M., Takeda, S., and Hashido, K. (2011). Identification of muscle-specific microRNAs in serum of muscular dystrophy animal models: Promising novel blood-based markers for muscular dystrophy. PLoS ONE, 6.","DOI":"10.1371\/journal.pone.0018388"},{"key":"ref_51","doi-asserted-by":"crossref","first-page":"482","DOI":"10.1093\/hmg\/ddn376","article-title":"Shifts in macrophage phenotypes and macrophage competition for arginine metabolism affect the severity of muscle pathology in muscular dystrophy","volume":"18","author":"Villalta","year":"2009","journal-title":"Hum. Mol. Genet."},{"key":"ref_52","doi-asserted-by":"crossref","first-page":"9500","DOI":"10.1093\/nar\/gkt724","article-title":"Extracellular microRNAs are dynamic non-vesicular biomarkers of muscle turnover","volume":"41","author":"Roberts","year":"2013","journal-title":"Nucleic Acids Res."},{"key":"ref_53","first-page":"S5","article-title":"Individual differences in the response to regular exercise","volume":"19","author":"Bouchard","year":"1995","journal-title":"Int. J. Obes. Relat. Metab. Disord."},{"key":"ref_54","doi-asserted-by":"crossref","first-page":"2004","DOI":"10.1152\/jappl.1991.71.5.2004","article-title":"Effects of gender, age, and fitness level on response of VO2max to training in 60-71 yr olds","volume":"71","author":"Kohrt","year":"1991","journal-title":"J. Appl. Physiol."},{"key":"ref_55","first-page":"964","article-title":"Variability in muscle size and strength gain after unilateral resistance training","volume":"37","author":"Hubal","year":"2005","journal-title":"Med. Sci. Sports Exerc."},{"key":"ref_56","doi-asserted-by":"crossref","first-page":"2232","DOI":"10.1152\/japplphysiol.00024.2007","article-title":"Cluster analysis tests the importance of myogenic gene expression during myofiber hypertrophy in humans","volume":"102","author":"Bamman","year":"2007","journal-title":"J. Appl. Physiol."},{"key":"ref_57","doi-asserted-by":"crossref","unstructured":"Bouchard, C., Blair, S.N., Church, T.S., Earnest, C.P., Hagberg, J.M., Hakkinen, K., Jenkins, N.T., Karavirta, L., Kraus, W.E., and Leon, A.S. (2012). Adverse metabolic response to regular exercise: Is it a rare or common occurrence?. PLoS ONE, 7.","DOI":"10.1371\/journal.pone.0037887"},{"key":"ref_58","doi-asserted-by":"crossref","first-page":"3377","DOI":"10.1113\/JP273480","article-title":"Refuting the myth of non-response to exercise training: \u2018non-responders\u2019 do respond to higher dose of training","volume":"595","author":"Montero","year":"2017","journal-title":"J. Physiol."},{"key":"ref_59","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/j.yjmcc.2018.10.008","article-title":"Voluntary exercise improves muscle function and does not exacerbate muscle and heart pathology in aged Duchenne muscular dystrophy mice","volume":"125","author":"Kogelman","year":"2018","journal-title":"J. Mol. Cell. Cardiol."},{"key":"ref_60","doi-asserted-by":"crossref","unstructured":"Gianola, S., Pecoraro, V., Lambiase, S., Gatti, R., Banfi, G., and Moja, L. (2013). Efficacy of muscle exercise in patients with muscular dystrophy: A systematic review showing a missed opportunity to improve outcomes. PLoS ONE, 8.","DOI":"10.1371\/journal.pone.0065414"},{"key":"ref_61","doi-asserted-by":"crossref","first-page":"659","DOI":"10.1177\/0883073814534316","article-title":"What can we learn from assisted bicycle training in a girl with dystrophinopathy? A case study","volume":"30","author":"Huijben","year":"2015","journal-title":"J. Child Neurol."},{"key":"ref_62","doi-asserted-by":"crossref","first-page":"492","DOI":"10.1016\/j.nmd.2014.03.001","article-title":"Anti-gravity training improves walking capacity and postural balance in patients with muscular dystrophy","volume":"24","author":"Berthelsen","year":"2014","journal-title":"Neuromuscul. Disord. NMD"},{"key":"ref_63","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1002\/mus.25039","article-title":"Body weight-supported training in Becker and limb girdle 2I muscular dystrophy","volume":"54","author":"Jensen","year":"2016","journal-title":"Muscle Nerve"},{"key":"ref_64","doi-asserted-by":"crossref","first-page":"816","DOI":"10.1177\/1545968313496326","article-title":"Assisted bicycle training delays functional deterioration in boys with Duchenne muscular dystrophy: The randomized controlled trial \u201cno use is disuse\u201d","volume":"27","author":"Jansen","year":"2013","journal-title":"Neurorehabil. Neural Repair"},{"key":"ref_65","doi-asserted-by":"crossref","first-page":"697","DOI":"10.1002\/mus.24451","article-title":"Different types of upper extremity exercise training in Duchenne muscular dystrophy: Effects on functional performance, strength, endurance, and ambulation","volume":"51","author":"Alemdaroglu","year":"2015","journal-title":"Muscle Nerve"}],"container-title":["Sports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2075-4663\/7\/3\/64\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T12:39:07Z","timestamp":1760186347000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2075-4663\/7\/3\/64"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,3,15]]},"references-count":65,"journal-issue":{"issue":"3","published-online":{"date-parts":[[2019,3]]}},"alternative-id":["sports7030064"],"URL":"https:\/\/doi.org\/10.3390\/sports7030064","relation":{},"ISSN":["2075-4663"],"issn-type":[{"value":"2075-4663","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,3,15]]}}}